Baidu
map

你们那个得奖的数据库,可以用来干什么?

2015-11-04 MedSci MedSci原创

10月27日,梅斯医学(MedSci)的疾病风险数据库项目获得了由国家科技部和上海市政府主办的2015“创业在上海”创新创业大赛的优胜奖,小编兴高采烈地写了一篇通讯稿庆祝(查看详细)。但是呢,当时奖状没有发下来,于是有一些粉丝在向小编数咨询数据库的相关信息的时候,表示通讯稿中没有证书的照片可信度不高,提醒小编把证书的照片加上去。Dang,dang,dang,附照片:作为一名临床医生,王辰院士说“医

10月27日,梅斯医学(MedSci)的疾病风险数据库项目获得了由国家科技部和上海市政府主办的2015“创业在上海”创新创业大赛的优胜奖,小编兴高采烈地写了一篇通讯稿庆祝(查看详细)。但是呢,当时奖状没有发下来,于是有一些粉丝在向小编数咨询数据库的相关信息的时候,表示通讯稿中没有证书的照片可信度不高,提醒小编把证书的照片加上去。Dang,dang,dang,附照片:





作为一名临床医生,王辰院士说“医生是天然的研究者,验证临床医生的经验的正确性还要靠研究”,“大庆研究”带头人李光伟教授说“会做科研的医生才能成为最优秀的医生”……可见医学研究对临床医生的重要性。但是,如何设计临床科研,如何积累有价值的科研数据,如何将收集的数据转换成科研的成果,这是许多临床医生永恒的伤痛与烦恼。尤其是在数据方面,许多临床医生不得不依托有关公司,而不能自己做为注册数据库的主体。

据悉,国内此前尚无生物标志物数据库方面的成功开发案例。你是不是还在羡慕国外的可以系统性地收录相关的研究信息的专业、大型数据库(如美国的BMDB数据库、欧盟的欧洲药品管理局建立的公共开放的电子注册数据库)?

不用再羡慕了,你可以选择梅斯医学的疾病风险数据库!梅斯医学的疾病风险数据库(简称“梅斯数据库”)通过大数据方法和人工编辑,从海量的学术文献中提取有关疾病风险因素及生物标志物的信息并对数据进行结构化管理,形成专业数据库系统。疾病风险数据库能够帮助指导医学科研的进一步方向、改善某些疾病临床诊疗模式,对基础医学研究者发现相关信号通路、病理学研究者了解疾病病因、临床检验医师开发新的检验项目、临床医师预测疾病的治疗和转归情况提供了便捷,满足了科研工作者提高相关文献检索效率的需求。

那么,为什么要选择梅斯医学的疾病风险数据库,它有什么优点?

1.免费

梅斯数据库是目前国内针对生物标志物、疾病风险等研究信息进行系统化整理的首个医学专业数据库免费开放平台。

2.大数据

梅斯数据库是将近5年国内外发表的各种生物医学文献(如学术期刊、专利、科研基因等)的关键数据(研究题目、主要内容、研究者等)进行结构化的合并及清洗,作为数据库的基础数据;应用命名实体识别和词义分析技术将基础数据中与生物标志物、疾病风险等相关的特征词通过计算机进行智能自动提取和标记;使用聚类分析、关联分析等数据挖掘技术发现实体间可能存在的潜在关联关系的数据库。


3.简便

梅斯数据库还是一个开放平台,以上分析结果根据治疗领域或风险因素类型进行分类,形成的一个可供检索的数据库系统。


4.丰富的增值服务


(1)研究资讯:以月度为周期,统计各钟疾病领域相关研究数量情况和发表期刊水平,并同历史数据进行比较,帮助了解研究动态。 


(2)个性化研究报告定制:用户指定感兴趣的疾病或标志物,由专业人员进行数据库检索,根据检索情况提供用户研究报告。 


(3)药物/品牌跟踪:根据用户需求,对某个(类)药物/品牌在数据库中的出现进行及时跟踪。


温馨提示:


1.MedSci还能提供全面的统计服务(MedSci 医学统计服务,让临床科研得心应手),帮助大家无忧做科研工作。


2.MedSci临床学院提供了在线视频课堂,为广大临床医生们提供丰富的科学研究的知识,包括医学试验的设计、数据的录入和统计学知识、数据库的相关知识、SCI论文的写作知识,帮助医学生和小医生们轻松学习科学研究。(点击进入MedSci临床学院


3.下载“MedSci医学”APP,随时掌握国内外最新医学资讯、MedSci临床学院课程免费看、快速查影响因子、详细了解期刊投稿要求、结交医学同道等等。(点击进入链接下载


梅斯医学(MedSci)主要从事医学知识更新和培训服务,旨在推动和加速临床医生的职业成长。梅斯医学(MedSci)是专业的临床研究与学术服务平台,降低临床医生从事临床研究的门槛,推动临床研究共享与协作,提高临床研究的便捷性和质量,发表更高质量的临床研究成果,为临床决策提供重要的证据支持与精准预测支持。我们的口号是改进医疗质量,为临床实践提供智慧、精准的决策支持,让医生与患者受益!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-10-07 1e0f4749m27(暂无匿称)

    愤世嫉俗的人当医生实在是堪忧!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-10-07 1e0f4749m27(暂无匿称)

    抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-10-07 1e0f4749m27(暂无匿称)

    梅斯医学让医生有了一个非常便捷的学习平台

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=141438, encodeId=bfad141438bb, content=愤世嫉俗的人当医生实在是堪忧!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:17:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141437, encodeId=050e14143ef9, content=抹去信息是让你比较便利学习,没让你侵犯权力去不当使用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:16:38 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141434, encodeId=6c4c141434ce, content=梅斯医学让医生有了一个非常便捷的学习平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Fri Oct 07 09:15:20 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80227, encodeId=64e58022e6e, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80228, encodeId=080480228e2, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80229, encodeId=e856802292b, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:47:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80221, encodeId=472880221d8, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80222, encodeId=e63780222c9, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80223, encodeId=b62e8022325, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=80224, encodeId=030e802243a, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Apr 22 07:46:00 CST 2016, time=2016-04-22, status=1, ipAttribution=)]
    2016-04-22 忠诚向上

    值得学习

    0

相关资讯

临床医生为什么要用数据库开展临床研究?

临床科研是每一位医生的必争之地,然而也是最痛的痛点之一。如何设计临床科研,如何积累有价值的科研数据,如何将收集的数据转换成科研的成果,并且将科研成果转换为公众健康意识是永恒的话题。 然而,如何积累有价值的科研数据更多的是执行层面的部分,包括如何设计CRFs、如何构造电子数据采集系统(EDC)、如何检查数据质量、清理和分析数据、整合数据库,也包括对数据录入员的管理等。串接这两部分的核心就是CR

在线课堂:预告:分子生物信息数据库

分子生物信息数据库种类繁多。归纳起来,大体可以分为4个大类,即基因组数据库、核酸和蛋白质一级结构序列数据库、生物大分子(主要是蛋白质)三维空间结构数据库、以上述3类数据库和文献资料为基础构建的二次数据库。来自MedSci学院的 张博士 为大家带来看关于分子生物信息数据库的课程讲解。一共4节课:课程表:分子生物信息数据库1: 基因组和分子生物信息数据库的介绍(链接)分子生物信息数据库2: 核酸序列数

梅斯医学获上海创业创新大赛优胜奖

10月27日,由国家科技部和上海市政府主办的浦江创新论坛创业者论坛在上海举行。会上还举行了2015“创业在上海”创新创业大赛颁奖仪式,梅斯医学作为本次大赛优胜队参加了这次活动。获奖名单会上,上海市副市长周波、科技部政策法规司司长贺德方、科技部火炬高技术产业开发中心副主任杨跃承等领导发表了精彩讲话。杨跃承主任引用习近平主席的话指出:新科技革命和产业变革对全球经济结构的重塑,好比“体育比赛换到了一个新

NCI公开全球很大的肿瘤基因数据库

在个体化治疗的广阔前景下,美国、英国和台湾都大力建设自己的肿瘤基因组数据库,希望通过肿瘤数据库的建设实现肿瘤患者个体化治疗,其中的变异基因分型后将成为肿瘤药物的攻击靶点,从而实现在基因组水平上对肿瘤进行靶向性治疗。 美国国家肿瘤研究所(NCI)已公开迄今为止规模最大的肿瘤相关的变异基因数据库,这些遗传信息可对肿瘤进行基因分型,其致癌基因的分子机制为靶向治疗提供依据。具有应用价值的是,研究

一些并不常见医学数据库介绍--AMED,CINAHL,ProQuest,BioOne,CPCI

AMED补充医学文献数据库AMED(Allied and Alternative Medieine)补充医学文献数据库最初是由英国图书馆医学信息中心(MIC)于2 955年研制的。MIC的功能之一是为《医学索引》(Index Medieus)和Medline提供英国医学文献的主题索引,它和一些其他数据库一起为从事医学文献检索的人员提供了很大的帮助。Medline作为医学领域一流的文献数据库,很显然

需要多少论文才能得到图灵奖?

今年3月25日,美国计算机协会(ACM)宣布,来自麻省理工学院的教授Michael Stonebraker获得2014年度“图灵奖”(第N年宣布N-1年得主),投石冲破水中天,一些与数据处理相关的微信群中喷发一股图灵奖议论热,有位教授在微信中赞叹“说数据库界一共四位传奇大师,太伟大了“,接着有几位教授提议在今年的教学PPT中,加上相关科普,激励年轻的数据库人。朋友们鼓励我来一篇非传记的、活泼一

Baidu
map
Baidu
map
Baidu
map